Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will ...

AbbVie’s model based fair value has been adjusted only slightly, moving from US$248.29 to US$248.86, which keeps the overall ...

AbbVie (NYSE: ABBV), a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged ...

AbbVie Inc. (NYSE:ABBV) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a ...

AbbVie Inc. (NYSE:ABBV) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. AbbVie Inc. (NYSE:ABBV) ...

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

In the current session, the stock is trading at $233.57, after a 0.52% spike. Over the past month, AbbVie Inc. (NYSE:ABBV) stock increased by 0.94%, and in the past year, by 40.22%. With performance ...

AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...

The latest announcement is out from AbbVie ( (ABBV) ).